{"id":"W3172413452","doi":"10.1200/jco.2021.39.15_suppl.9509","title":"Overall survival benefit from tebentafusp in patients with best response of progressive disease.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cohort; Pembrolizumab; Progressive disease; Oncology; Interim analysis; Randomized controlled trial; Disease; Nuclear medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002158382,0.0001441534,0.001352118,0.00008218283,0.00002596248,0.000005925738,0.0002450243,0.0005056378,0.0008865405],"category_scores_gemma":[0.004612009,0.00009317858,0.0003277023,0.0001449567,0.0004407464,0.00007755033,0.0001121081,0.0008771637,0.00001096559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005899993,"about_ca_system_score_gemma":0.0009877236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001640549,"about_ca_topic_score_gemma":0.00004985728,"domain_scores_codex":[0.9954518,0.002078312,0.001859068,0.0002409767,0.0001263569,0.0002434761],"domain_scores_gemma":[0.9929487,0.004670577,0.001397996,0.0002322138,0.0006216046,0.0001288826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05884315,0.005812829,0.9035583,0.00000936907,0.0005684874,0.0004295108,0.00003109864,0.000004840123,0.0008790228,0.0001907976,0.0005354165,0.02913722],"study_design_scores_gemma":[0.0102043,0.006645468,0.9642212,0.0001632432,0.0002675583,0.000008375931,0.00006002118,0.000001612003,0.0009332856,0.0007323536,0.01664983,0.0001127276],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994221,0.001560686,0.00002672808,0.002712372,0.001041933,0.0001314118,0.00008611605,0.000002676535,0.0002170593],"genre_scores_gemma":[0.9953573,0.0001373361,0.003228825,0.0007407662,0.0001280821,0.000002357082,0.00001723266,0.00001146817,0.000376608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06066297,"threshold_uncertainty_score":0.9706996,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07157264237981696,"score_gpt":0.4179175306840169,"score_spread":0.3463448883041999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}